Facebook Linkedin RSS Twitter Youtube
Home 2023

Intravenous administration

Nanoparticle Side Effects Mitigated via Complement Regulation
Featured

Nanoparticle Side Effects Mitigated via Complement Regulation

Sophia Ktori -
0
Gene Therapy Reduces Hearing Loss Caused by Norrie Disease in Mice
Drug Discovery

Gene Therapy Reduces Hearing Loss Caused by Norrie Disease in Mice

Julianna LeMieux, PhD -
0
Type 2 Diabetes Managed via Artificial Pancreas in Trial
News

Type 2 Diabetes Managed via Artificial Pancreas in Trial

Anjali A. Sarkar, PhD -
0
Switching Biologics from IV to SQ Routes
Drug Discovery

Switching Biologics from IV to SQ Routes

Kathy Vuksanaj -
0
GlaxoSmithKline (GSK) – Otilimab
News

GlaxoSmithKline (GSK) – Otilimab

Alex Philippidis -
0
Tuberculosis Vaccine Efficacy Boosted Dramatically by IV Administration
Drug Discovery

Tuberculosis Vaccine Efficacy Boosted Dramatically by IV Administration

Sophia Ktori -
0
Tekmira Wins $5M Milestone from Alnylam as Patisiran Enters Phase III
News

Tekmira Wins $5M Milestone from Alnylam as Patisiran Enters Phase III

GEN Staff Writer -
0
U.S. Navy CRADA Will Evaluate Intravenous PFC-delivered Oxygen for Wounds
Infectious Diseases

U.S. Navy CRADA Will Evaluate Intravenous PFC-delivered Oxygen for Wounds

GEN Staff Writer -
0
France Clears United Therapeutics’ Intravenous Remodulin for PAH Therapy
News

France Clears United Therapeutics’ Intravenous Remodulin for PAH Therapy

GEN Staff Writer -
0
Genzyme’s mAb for Multiple Sclerosis Succeeds in Second Phase III Trial
Drug Discovery

Genzyme’s mAb for Multiple Sclerosis Succeeds in Second Phase III Trial

GEN Staff Writer -
0
12Page 1 of 2
Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.